Examining the 'gold standard': A comparative critical analysis of three consecutive decades of monopolar transurethral resection of the prostate (TURP) outcomes

BJU International

Volumn 110, Issue 11, 2012, Pages 1595-1601

  Mayer, Erik K ^a   Kroeze, Stephanie G C ^b   Chopra, Samarth ^c   Bottle, Alex ^d   Patel, Anup ^a  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ST VINCENT S HOSPITAL   (Australia)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

benign prostatic hyperplasia; lower urinary tract symptoms; monopolar transurethral resection of prostate; prostate

Indexed keywords

BLADDER CATHETERIZATION; GOLD STANDARD; LENGTH OF STAY; LOWER URINARY TRACT SYMPTOM; MALE GENITAL TRACT PARAMETERS; MICTURITION DISORDER; MONOPOLAR TRANSURETHRAL RESECTION OF THE PROSTATE; OPERATION DURATION; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE VOLUME; PROSTATE WEIGHT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TRANSFUSION; TRANSURETHRAL RESECTION; URINARY TRACT INFECTION; URINE RETENTION;

EID: 84870903480     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11119.x     Document Type: Review

References (18)

1. Reich O, Gratzke C, Bachmann A, et al,. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 2008; 180: 246-9
2. Rassweiler J, Teber D, Kuntz R, Hofmann R,. Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol 2006; 50: 969-80
3. Wendt-Nordahl G, Bucher B, Hacker A, Knoll T, Alken P, Michel MS,. Improvement in mortality and morbidity in transurethral resection of the prostate over 17 years in a single center. J Endourol 2007; 21: 1081-7
4. Greco KA, McVary KT,. The role of combination medical therapy in benign prostatic hyperplasia. Int J Impot Res 2008; 20 (Suppl. 3): S33-43
5. Izard J, Nickel JC,. Impact of medical therapy on transurethral resection of the prostate: two decades of change. BJU Int 2011; 108: 89-93
6. Borboroglu PG, Kane CJ, Ward JF, Roberts JL, Sands JP,. Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol 1999; 162: 1307-10
7. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC,. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989; 141: 243-7
8. Madersbacher S, Marberger M,. Is transurethral resection of the prostate still justified? BJU Int 1999; 83: 227-37
9. Shin YS, Park JK,. Changes in surgical strategy for patients with benign prostatic hyperplasia: 12-year single-center experience. Korean J Urol 2011; 52: 189-93
10. Bosch JL, Bohnen AM, Groeneveld FP,. Validity of digital rectal examination and serum prostate specific antigen in the estimation of prostate volume in community-based men aged 50 to 78 years: the Krimpen Study. Eur Urol 2004; 46: 753-9
11. Hahn RG,. The use of ethanol to monitor fluid absorption during transurethral resection of the prostate. Scand J Urol Nephrol 1999; 33: 277-83
12. Uchida T, Ohori M, Soh S, et al,. Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology 1999; 53: 98-105
13. Donohue JF, Hayne D, Karnik U, Thomas DR, Foster MC,. Randomized, placebo-controlled trial showing that finasteride reduces prostatic vascularity rapidly within 2 weeks. BJU Int 2005; 96: 1319-22
14. Logie J, Clifford GM, Farmer RD,. Incidence, prevalence and management of lower urinary tract symptoms in men in the UK. BJU Int 2005; 95: 557-62
15. Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P,. The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up. BJU Int 2004; 93: 745-50
16. Flanigan RC, Reda DJ, Wasson JH, Anderson RJ, Abdellatif M, Bruskewitz RC,. 5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study. J Urol 1998; 160: 12-7
17. Clavien PA, Barkun J, de Oliveira ML, et al,. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250: 187-96
18. Agha R, Cooper D, Muir G,. The reporting quality of randomised controlled trials in surgery: a systematic review. Int J Surg 2007; 5: 413-22